(213) 797-0902 Wavelaconsult@gmail.com

Important COVID-19 Message:

Due to the current situation we have instituted important changes to our clinic to increase safety of our patients & staff:

  1. We have the option of selected few Private Visits which allows the patient to be alone in the whole clinic with the doctor & his assistant. No other patients would be scheduled at the same time.  (Please inquire specifically for this option)
  2. All of our regular visits are spaced out and we try our best to avoid having more than one customer in the same room or area at the same time.
  3. We offer telemedicine & virtual visits for consultations. We also offer same day consultation and procedure.

In addition we have implemented the following extra precautions beyond the CDC requirements for all visits:

  1. The staff and the doctor wear mask and protective equipment at all times.
  2. We ask our customers to wear a mask when in the clinic at all times.
  3.  We have implemented extra hand washing and room cleaning.
  4. We ask our customers that arrive early to call our office and wait in the car.
  5. Any patient with recent symptoms of fever or recent contact with someone with symptoms are not allowed in the room.
  6. The doctor wears a double mask, including a face shield & N-95 high filter mask during procedures in addition to additional body gown.

We understand that many of our patients may be experiencing discomfort and pain that require procedures without delay.  Also, we understand that delay can lead to further pain, complications & possible decreased quality of life if delayed even by few weeks.  A prompt procedure can avoid these issues.

Low-Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapyjsm_2498 2

Ilan Gruenwald, MD, Boaz Appel, MD, and Yoram Vardi, MD
Neuro-urology Unit, Rambam Healthcare Campus, Haifa, Israel

Results. “Twenty-nine men (mean age of 61.3) completed the study. Their mean IIEF-ED scores increased from
8.8 1 (baseline) to 12.3 1 at FU1 (P = 0.035). At FU2 (on active PDE5i treatment), their IIEF-ED further
increased to 18.8 1 (P < 0.0001), and 72.4% (P < 0.0001) reached an EHS of 3 (allowing full sexual intercourse).
A significant improvement (P = 0.0001) in penile hemodynamics was detected after treatment and this improvement
significantly correlated with increases in the IIEF-ED (P < 0.05). No noteworthy adverse events were reported.
Conclusions. Penile LI-ESWT is a new modality that has the potential to treat a subgroup of severe ED patients.
These preliminary data need to be reconfirmed by multicenter sham control studies in a larger group of ED patients. ”

Full Text:

http://www.jsm.jsexmed.org/article/S1743-6095(15)33720-6/fulltext

 

Los Angeles Men’s Health Clinic